<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To investigate the association between type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, <z:chebi fb="105" ids="17234">glucose</z:chebi>-lowering therapies (monotherapy with either <z:chebi fb="0" ids="6801">metformin</z:chebi>, sulphonylurea or insulin) and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> risk in Taiwan </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Using Taiwan's National Health Research Institutes database of 1,000,000 random subjects from 2000-2008, we found 61777 patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> (age â‰¥20 years) and 677378 enrollees with no record of <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: After adjusting for age and sex, we found patients with <z:mp ids='MP_0002055'>diabetes</z:mp> to have significantly higher risk of <z:hpo ids='HP_0000001'>all</z:hpo> <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> (OR: 1.176; 95% CI: 1.149-1.204, P &lt; 0.001) </plain></SENT>
<SENT sid="3" pm="."><plain>Diabetic patients treated with insulin or <z:chebi fb="0" ids="26831">sulfonylureas</z:chebi> had significantly higher risk of <z:hpo ids='HP_0000001'>all</z:hpo> <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e>, compared to those treated with <z:chebi fb="0" ids="6801">metformin</z:chebi> (OR: 1.583; 95% CI: 1.389-1.805, P &lt; 0.001 and OR: 1.784; 95% CI: 1.406-2.262, P &lt; 0.001) </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="0" ids="6801">Metformin</z:chebi> treatment was associated with a decreased risk of colon and <z:hpo ids='HP_0002896'>liver cancer</z:hpo> compared to sulphonylureas or insulin treatment </plain></SENT>
<SENT sid="5" pm="."><plain><z:chebi fb="0" ids="26831">Sulfonylureas</z:chebi> treatment was associated with an increased risk of breast and <z:e sem="disease" ids="C0242379" disease_type="Neoplastic Process" abbrv="">lung cancer</z:e> compared to <z:chebi fb="0" ids="6801">metformin</z:chebi> therapy </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSIONS: Taiwanese with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> are at a high risk of breast, prostate, colon, lung, liver and <z:hpo ids='HP_0002894'>pancreatic cancer</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>Those treated with insulin or <z:chebi fb="0" ids="26831">sulfonylureas</z:chebi> monotherapy are more likely to develop colon and <z:hpo ids='HP_0002896'>liver cancer</z:hpo> than those treated with <z:chebi fb="0" ids="6801">metformin</z:chebi> </plain></SENT>
</text></document>